Diabetics could soon find some much-needed relief now that US FDA has approved Sanuwave Inc.'s dermaPACE system to tackle diabetic foot ulcers.
The external (extracorporeal) shockwave device, the first of its kind, treats chronic, full-thickness ulcers with wound areas measuring no larger than 16 cm2 – about the size of a soda...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?